BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34059692)

  • 21. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
    Choi KH; Kim JY; Lee DS; Lee YH; Lee SW; Sung S; Park HH; Yoon SC; Hur SY; Park JS; Kim YS
    Medicine (Baltimore); 2018 Apr; 97(16):e0517. PubMed ID: 29668638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
    Ijaz T; Eifel PJ; Burke T; Oswald MJ
    Gynecol Oncol; 1998 Aug; 70(2):241-6. PubMed ID: 9740698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.
    Escande A; Gouy S; Mazeron R; Bentivegna E; Bacorro W; Maroun P; Schernberg A; Oberlander AS; Dumas I; Genestie C; Deutsch E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2017 Mar; 144(3):541-546. PubMed ID: 28095994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
    Viswanathan AN; Moughan J; Small W; Levenback C; Iyer R; Hymes S; Dicker AP; Miller B; Erickson B; Gaffney DK
    Int J Gynecol Cancer; 2012 Jan; 22(1):123-31. PubMed ID: 22193645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery.
    Haasbeek CJ; Uitterhoeve AL; van der Velden J; González DG; Stalpers LJ
    Radiother Oncol; 2008 Nov; 89(2):197-204. PubMed ID: 18237803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
    Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
    J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
    Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
    Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins.
    Lee YH; Kim YS; Choi KH; Sung S; Jeong BK; Ha IB; Kang KM; Lee J; Lee JH; Kim SH
    Int J Clin Oncol; 2022 Jan; 27(1):202-212. PubMed ID: 34677738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodine-125 radioactive seed tissue implantation as a remedy treatment for recurrent cervical cancer.
    Han L; Li C; Wang J; He X; Zhang X; Yang J; Liu G
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C176-C180. PubMed ID: 28230013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.